Published in Surgery Litigation and Law Weekly, June 17th, 2005
"We have completed our preliminary review of the results of our CTA clinical trial and, based on those results, intend to move forward with filing a PMA by the end of the third quarter," said Charles Sherwood, PhD, president and chief executive officer.
Headquartered in Woburn, Massachusetts, Anika Therapeutics develops, manufactures and commercializes therapeutic products and devices intended to promote the repair, protection and healing of bone,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly